Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | November 13, 2025 12:06pm

Gainers

  • Mersana Therapeutics (NASDAQ:MRSN) stock increased by 205.0% to $27.05 during Thursday's regular session. The market value of their outstanding shares is at $44.2 million.
  • Clearmind Medicine (NASDAQ:CMND) shares rose 28.23% to $0.4. The market value of their outstanding shares is at $1.6 million.
  • Outlook Therapeutics (NASDAQ:OTLK) stock moved upwards by 22.65% to $1.57. The market value of their outstanding shares is at $56.8 million.
  • Apollomics (NASDAQ:APLM) stock rose 18.52% to $19.58. The market value of their outstanding shares is at $35.4 million.
  • Mainz Biomed (NASDAQ:MYNZ) stock increased by 17.27% to $1.59. The company's market cap stands at $6.2 million.
  • AEON Biopharma (AMEX:AEON) stock rose 14.08% to $1.04. The company's market cap stands at $10.6 million.

Losers

  • Korro Bio (NASDAQ:KRRO) shares decreased by 80.7% to $6.07 during Thursday's regular session. The market value of their outstanding shares is at $295.0 million. The company's, Q3 earnings came out yesterday.
  • Applied Therapeutics (NASDAQ:APLT) stock fell 59.03% to $0.37. The company's market cap stands at $131.0 million. As per the news, the Q3 earnings report came out today.
  • Ardent Health (NYSE:ARDT) shares declined by 33.17% to $9.39. The company's market cap stands at $2.0 billion. The company's, Q3 earnings came out yesterday.
  • Zynex (NASDAQ:ZYXI) stock declined by 32.97% to $0.74. The market value of their outstanding shares is at $33.2 million.
  • Absci (NASDAQ:ABSI) shares decreased by 21.77% to $2.66. The market value of their outstanding shares is at $508.3 million. The company's, Q3 earnings came out yesterday.
  • Claritev (NYSE:CTEV) stock declined by 21.2% to $46.2. The company's market cap stands at $968.7 million. As per the press release, Q3 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABSI AEON APLM APLT ARDT CMND CTEV KRRO MRSN MYNZ OTLK ZYXI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist